OKYO Pharma Ltd - Form 6-K Summary
Business Context and Reporting Period
OKYO Pharma Ltd, a foreign private issuer, filed this Form 6-K on July 21, 2026. The filing serves to announce a corporate presentation scheduled for the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference on July 22, 2026.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural filing to distribute a news announcement and does not contain audited or unaudited financial statements.
Material Changes
No material changes to financial position or operations are reported in this document. The filing solely references the upcoming conference presentation.
Guidance, Outlook, and Risks
The filing does not contain specific guidance, management commentary on future performance, or a discussion of risks and contingencies. It notes that the attached news announcement (Exhibit 99.1) is furnished but not deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934.
Key Facts for Investors to Verify
- Review the attached Exhibit 99.1 (News Announcement) for details regarding the July 22, 2026, conference presentation.
- Confirm the company's current financial status through its most recent Form 20-F or other periodic reports, as this 6-K contains no financial data.
- Verify the incorporation of this report by reference into the Company's Registration Statement on Form F-3 (Reg. No. 333-293145).